DOI QR코드

DOI QR Code

Use of Quantitative Vertebral Bone Marrow Fat Fraction to Assess Disease Activity and Chronicity in Patients with Ankylosing Spondylitis

  • Ga Young Ahn (Division of Rheumatology, Department of Internal Medicine, Korea University Guro Hospital) ;
  • Bon San Koo (Division of Rheumatology, Department of Internal Medicine, Inje University College of Medicine) ;
  • Kyung Bin Joo (Department of Radiology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Tae-Hwan Kim (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Seunghun Lee (Department of Radiology, Hanyang University Hospital for Rheumatic Diseases)
  • Received : 2020.07.26
  • Accepted : 2021.02.20
  • Published : 2021.10.01

Abstract

Objective: We quantitatively measured the fat fraction (FF) in the vertebrae of patients with ankylosing spondylitis (AS) using magnetic resonance imaging (MRI) and investigated the role of FF as an indicator of both active inflammation and chronicity. Materials and Methods: A total of 52 patients with AS who underwent spinal MRI were retrospectively evaluated. The FF values of the anterosuperior and anteroinferior corners of the bone marrow in the L1-S1 spine were assessed using the modified Dixon technique. AS activity was measured using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), AS Disease Activity Score (ASDAS), and serum inflammatory marker levels. AS disease chronicity was assessed by AS disease duration and the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). Univariable and multivariable regression analyses were conducted to investigate the correlation between FF and other clinical characteristics. Results: The mean FF ± standard deviation of the total lumbar spine was 43.0% ± 11.3%. At univariable analysis, spinal FF showed significant negative correlation with BASDAI (β = -0.474, p = 0.002) and ASDAS with C-reactive protein (ASDAS-CRP; β = -0.478, p = 0.002) and a significant positive correlation with AS disease duration (β = 0.440, p = 0.001). After adjusting for patient age, sex, and total mSASSS score, spinal FF remained significantly negatively correlated with BASDAI (β = -0.543, p < 0.001), ASDAS-CRP (β = -0.568, p < 0.001), and ASDAS with erythrocyte sedimentation rate (β = -0.533, p = 0.001). Spinal FF was significantly lower in patients with very high disease activity (ASDAS-CRP > 3.5) than in those with only high disease activity (2.1 ≤ ASDAS-CRP ≤ 3.5) (p = 0.010). Conclusion: Spinal FF may help assess both AS disease activity and chronicity.

Keywords

References

  1. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368  https://doi.org/10.1002/art.1780270401
  2. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-2291 
  3. Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-129  https://doi.org/10.1136/ard.2004.020503
  4. Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 2016;374:2563-2574  https://doi.org/10.1056/NEJMra1406182
  5. Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis. Arthritis Rheumatol 2014;66:2958-2967  https://doi.org/10.1002/art.38792
  6. Machado PM, Baraliakos X, van der Heijde D, Braun J, Landewe R. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2016;75:1486-1493  https://doi.org/10.1136/annrheumdis-2015-208011
  7. Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Fat metaplasia on MRI of the sacroiliac joints increases the propensity for disease progression in the spine of patients with spondyloarthritis. RMD Open 2017;3:e000399 
  8. Kim NR, Choi JY, Hong SH, Jun WS, Lee JW, Choi JA, et al. "MR corner sign": value for predicting presence of ankylosing spondylitis. AJR Am J Roentgenol 2008;191:124-128  https://doi.org/10.2214/AJR.07.3378
  9. Schneider M, Janas G, Lugauer F, Hoppe E, Nickel D, Dale BM, et al. Accurate fatty acid composition estimation of adipose tissue in the abdomen based on bipolar multi-echo MRI. Magn Reson Med 2019;81:2330-2346  https://doi.org/10.1002/mrm.27557
  10. Hutton C, Gyngell ML, Milanesi M, Bagur A, Brady M. Validation of a standardized MRI method for liver fat and T2* quantification. PLoS One 2018;13:e0204175 
  11. Regnell SE, Peterson P, Trinh L, Broberg P, Leander P, Lernmark A, et al. Pancreas volume and fat fraction in children with Type 1 diabetes. Diabet Med 2016;33:1374-1379  https://doi.org/10.1111/dme.13115
  12. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24  https://doi.org/10.1136/ard.2008.094870
  13. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-2285 
  14. Machado P, Landewe R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47-53  https://doi.org/10.1136/ard.2010.138594
  15. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645-2654  https://doi.org/10.1002/art.38070
  16. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60:1122-1134  https://doi.org/10.1002/mrm.21737
  17. Maas M, Akkerman EM, Venema HW, Stoker J, Den Heeten GJ. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers. J Comput Assist Tomogr 2001;25:691-697  https://doi.org/10.1097/00004728-200109000-00005
  18. Ioannidis JPA. The proposal to lower P value thresholds to. 005. JAMA 2018;319:1429-1430  https://doi.org/10.1001/jama.2018.1536
  19. Koo BS, Song Y, Shin JH, Lee S, Kim TH. Evaluation of disease chronicity by bone marrow fat fraction using sacroiliac joint magnetic resonance imaging in patients with spondyloarthritis: a retrospective study. Int J Rheum Dis 2019;22:734-741  https://doi.org/10.1111/1756-185X.13485
  20. Pedersen SJ, Weber U, Said-Nahal R, Sorensen IJ, Loft AG, Kollerup G, et al. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor. Scand J Rheumatol 2019;48:185-197  https://doi.org/10.1080/03009742.2018.1506822
  21. Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011;63:2215-2225  https://doi.org/10.1002/art.30393
  22. Maksymowych WP, Learch T, Lambert RG, Ward M, Haroon N, Inman R, et al. Development and validation of the spondyloarthritis radiography module for calibration of readers using the modified Stoke Ankylosing Spondylitis Spine Score. Arthritis Care Res (Hoboken) 2014;66:55-62  https://doi.org/10.1002/acr.22083
  23. Li G, Xu Z, Gu H, Li X, Yuan W, Chang S, et al. Comparison of chemical shift-encoded water-fat MRI and MR spectroscopy in quantification of marrow fat in postmenopausal females. J Magn Reson Imaging 2017;45:66-73  https://doi.org/10.1002/jmri.25351
  24. Zhang L, Li S, Hao S, Yuan Z. Quantification of fat deposition in bone marrow in the lumbar vertebra by proton MRS and in-phase and out-of-phase MRI for the diagnosis of osteoporosis. J Xray Sci Technol 2016;24:257-266  https://doi.org/10.3233/XST-160549
  25. Karampinos DC, Ruschke S, Dieckmeyer M, Diefenbach M, Franz D, Gersing AS, et al. Quantitative MRI and spectroscopy of bone marrow. J Magn Reson Imaging 2018;47:332-353  https://doi.org/10.1002/jmri.25769
  26. Ziegeler K, Eshkal H, Schorr C, Sieper J, Diekhoff T, Makowski MR, et al. Age-and sex-dependent frequency of fat metaplasia and other structural changes of the sacroiliac joints in patients without axial spondyloarthritis: a retrospective, cross-sectional MRI study. J Rheumatol 2018;45:915-921  https://doi.org/10.3899/jrheum.170904
  27. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-984 
  28. Sellas I Fernandez A, Juanola Roura X, Alonso Ruiz A, Rosas J, Medina Luezas J, Collantes Estevez E, et al. Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study). Rheumatol Int 2017;37:1817-1823  https://doi.org/10.1007/s00296-017-3814-2
  29. Bray TJP, Jones A, Bennett AN, Conaghan PG, Grainger A, Hodgson R, et al. Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK. Rheumatology (Oxford) 2019;58:1831-1838  https://doi.org/10.1093/rheumatology/kez173
  30. Bradbury LA, Hollis KA, Gautier B, Shankaranarayana S, Robinson PC, Saad N, et al. Diffusion-weighted imaging is a sensitive and specific magnetic resonance sequence in the diagnosis of ankylosing spondylitis. J Rheumatol 2018;45:771-778  https://doi.org/10.3899/jrheum.170312
  31. Ren C, Zhu Q, Yuan H. Mono-exponential and bi-exponential model-based diffusion-weighted MR imaging and IDEAL-IQ sequence for quantitative evaluation of sacroiliitis in patients with ankylosing spondylitis. Clin Rheumatol 2018;37:3069-3076  https://doi.org/10.1007/s10067-018-4321-x
  32. Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276-1281  https://doi.org/10.1136/ard.2007.073098
  33. Xu M, Lin Z, Deng X, Li L, Wei Y, Liao Z, et al. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology (Oxford) 2011;50:1466-1472  https://doi.org/10.1093/rheumatology/ker087
  34. Pedersen SJ, Sorensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010;69:1065-1071  https://doi.org/10.1136/ard.2009.111187
  35. Baraliakos X, Heldmann F, Callhoff J, Suppiah R, McQueen FM, Krause D, et al. Quantification of bone marrow edema by magnetic resonance imaging only marginally reflects clinical neck pain evaluation in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2016;43:2131-2135  https://doi.org/10.3899/jrheum.150553
  36. Ez-Zaitouni Z, Bakker PA, van Lunteren M, de Hooge M, van den Berg R, Reijnierse M, et al. The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts. Ann Rheum Dis 2017;76:1731-1736 https://doi.org/10.1136/annrheumdis-2017-211486